During the past decade, AdventHealth Orlando Infusion Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AdventHealth Orlando Infusion Center" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AdventHealth Orlando Infusion Center" are "Advanced Solid Tumors" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "KRAS p.G12C Mutant Advanced Solid Tumors" (1 trials), "Melanoma" (1 trials) and "Metastatic Solid Tumors" (1 trials). Many other conditions were trialed in "AdventHealth Orlando Infusion Center" in a lesser frequency.

Most popular intervention types in "AdventHealth Orlando Infusion Center" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Binimetinib" (2 trials), "Encorafenib" (2 trials), "Anti PD-1/L1" (1 trials), "Axitinib" (1 trials) and "Midazolam" (1 trials). Other intervention names were less common.

The vast majority of trials in "AdventHealth Orlando Infusion Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "AdventHealth Orlando Infusion Center". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in AdventHealth Orlando Infusion Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AdventHealth Orlando Infusion Center, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".